Key Slides on Information Needed to Determine HBV Treatment Candidacy Based on APASL Guidelines

Review APASL guideline recommendations informing HBV treatment candidacy, including fibrosis assessments and ongoing monitoring.
Grace LH Wong, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.04 MB
Released: March 5, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from:
Gilead Sciences, Inc.

Related Content

W. Grace L. H. Wong 博士,来自 Clinical Care Options (CCO)的慢性 HBV 患者的 HCC 风险评估和跨学科管理

Grace LH Wong, 医学博士 Released: April 16, 2021

Dr. Grace L. H. Wong on HCC risk assessment and interdisciplinary management of HCC in patients with chronic HBV, from Clinical Care Options (CCO)

Grace LH Wong, MD Released: April 15, 2021

Clinical Care Options (CCO) expert commentary on incorporating family history into clinical decision-making when caring for patients with hepatitis B

Anna Christina L. dela Cruz, MD Released: April 15, 2021

Download free expert-authored slides reviewing key data and AASLD guidance on HCC risk, considerations for treatment, and HCC monitoring

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD Released: March 26, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue